CIK 0001951222 · Non-accelerated filer<br>Emerging growth company
SEALSQ Corp
Sign in to watch- Ticker
- LAES
- Exchange
- Nasdaq
- Industry
- Semiconductors & Related Devices
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- other
- Phone
- 212-336-2039
- Business address
- AVENUE LOUIS-CASAI 58, COINTRIN, Switzerland, 1216
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $170,294
- in 3 filings, $170K under 10b5-1 plans
Net −$170,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 | +15,000 | $0.01 | $150 | 15,000 |
| 2026-08-03 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −15,000 | 15,000 | ||
| 2026-07-08 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 | −15,000 | $2.82 | $42K | 0 |
| 2026-07-06 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 | +15,000 | $0.01 | $150 | 15,000 |
| 2026-07-06 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −15,000 | 30,000 | ||
| 2026-06-16 | Ward Peter Director | Option exercise | +366,746 | $0.01 | $4K | 367,061 |
| 2026-06-16 | Ward Peter Director | Shares withheld for taxes | −96,530 | $3.07 | $296K | 270,531 |
| 2026-06-16 | Ward Peter Director | Option exercise · Employee Stock Option Plan (right to buy) | −13,649 | 0 | ||
| 2026-06-16 | Ward Peter Director | Option exercise · Employee Stock Option Plan (right to buy) | −353,097 | 0 | ||
| 2026-06-05 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −143 | $3.51 | $502 | 250,431 |
| 2026-06-05 | Moreira Carlos Chief Executive Officer | Sale 10b5-1 | −300 | $3.51 | $1K | 696,215 |
| 2026-06-03 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 | −15,000 | $3.51 | $53K | 0 |
| 2026-06-03 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −5,582 | $3.53 | $20K | 250,574 |
| 2026-06-03 | Moreira Carlos Chief Executive Officer | Sale 10b5-1 | −7,005 | $3.53 | $25K | 696,515 |
| 2026-06-02 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $3.69 | $37K | 256,156 |
| 2026-06-02 | Moreira Carlos Chief Executive Officer | Sale 10b5-1 | −10,000 | $3.69 | $37K | 703,520 |
| 2026-06-01 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 | +15,000 | $0.01 | $150 | 15,000 |
| 2026-06-01 | Enguent Jean-Pierre Vice President, R&DSS | Grant or award · Employee Stock Option Plan (right to buy) 10b5-1 | +60,000 | 60,000 | ||
| 2026-06-01 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise · Employee Stock Option Plan (right to buy) 10b5-1 | −15,000 | 45,000 | ||
| 2026-05-29 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 | −10,000 | $3.51 | $35K | 266,156 |
Page 2 of 5 · 82 trades